Both in Pharmaceuticals
Xilio Therapeutics vs Rein Therapeutics
Over the past year XLO returned −31.1% and RNTX returned −47.8%; their daily moves had a correlation of 0.01.
XLO −31.1% RNTX −47.8%Growth of $1, one year, split-adjusted
| Metric | XLO | RNTX |
|---|---|---|
| Price | $8.01 | $0.7042 |
| Market cap | $52.7M | $60.7M |
| Today | +9.58% | +20.75% |
| 1 month | −11.5% | −2.3% |
| 6 months | +1.1% | −51.4% |
| Year to date | −10.6% | −39.3% |
| 1 year | −27.6% | −51.1% |
| Revenue growth (YoY) | +131.2% | — |
| Gross margin | 100.0% | — |
| Net margin | −34.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.8× | — |
| Net cash | $136.0M | $40.6M |
| Dividend yield | — | — |
| Volatility (60d) | 33.3% | 97.1% |
| Short % of float | 10.1% | 2.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).